MIR431 has previously been shown to be downregulated in AML and overexpression induced downregulation of TGF-β and EMT markers like fibronectin, α-SMA, and vimentin (Jiang et al., 2018). The gene discussed is MIR431; the disease is acute myeloid leukemia.